Jesy Nelson's fight for newborn SMA screening wins NHS policy change by 2026

Singer Jesy Nelson has been campaigning for wider newborn screening after her twins were diagnosed with a rare muscle-wasting disease. The condition, known as SMA Type 1, often proves fatal before a child’s second birthday if untreated. Now, her efforts have led to a major change in NHS policy from 2026. Nelson’s 10-month-old twins, Ocean and Story, were diagnosed with SMA Type 1, a severe condition that causes muscle deterioration. Without treatment, most children with the disease do not survive past two years. The twins currently require daily medical care to manage their symptoms.

Nelson has pushed for earlier detection through newborn screening. Her campaign gathered over 100,000 signatures on a petition, forcing a parliamentary debate. The government has now announced that from October 2026, more than 400,000 babies in England will be tested for SMA Type 1 at birth. However, the screening will not be available everywhere immediately. Only selected areas will introduce the tests at first. Nelson continues to advocate for nationwide coverage, hoping all newborns will benefit from early diagnosis. Despite the challenges, she remains hopeful that her twins will live longer, healthier lives with the right treatment. Recently, she shared a video on Instagram showing a peaceful walk through the forest with Ocean and Story.

The NHS will begin screening newborns for SMA Type 1 in 2026, starting in limited regions. Nelson’s campaign has already secured a parliamentary discussion and a policy shift. Early detection could give children like her twins a better chance at survival.